ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell therapy tested in Tough-to-Treat liver cancer
Disease control Recruiting nowThis is an early-stage study testing a new type of personalized immune cell therapy (called CAR-T) for people with advanced liver cancer that has stopped responding to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target a specifi…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo tested for Tough-to-Treat liver cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called WGI-0301 to the standard drug sorafenib can help control advanced liver cancer. It is for adults whose cancer has worsened after trying a previous type of immunotherapy. The main goals are to find the safest dose of…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Scientists test 'Living Drug' that hunts liver cancer cells
Disease control Recruiting nowThis study is testing a new type of immune cell therapy for adults with advanced liver cancer that cannot be removed by surgery or has returned after other treatments. Doctors will give patients specially engineered immune cells designed to find and attack cancer cells. The study…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 'Super' cell therapy tested for tough liver cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new type of personalized cell therapy for patients with advanced liver cancer. The therapy, called 'Super CAR-T,' involves modifying a patient's own immune cells to target a specific protein (GPC3) found on their cancer cells. The mai…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Radiation boost for liver cancer treatment?
Disease control Recruiting nowThis study is testing whether adding a targeted form of radiation therapy to standard immunotherapy helps people with advanced liver cancer that has grown into major blood vessels. It will enroll 128 patients to compare how long the cancer stays under control and how long patient…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Supercharged immune cells take aim at tough liver cancers
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for patients with advanced liver cancer that has come back or stopped responding to other treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack u…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC